However, the path to widespread adoption is not without its challenges. From regulatory hurdles to issues of variable efficacy and patient education, the non-invasive neurotech sector will need to navigate a complex landscape as it moves towards commercialization.

Despite these challenges, the potential benefits of this technology are immense. If successful, non-invasive neurotech could offer more accessible, cost-effective, and potentially more targeted treatments for conditions that affect millions of people worldwide. It could also open up new avenues for understanding and interacting with the human brain, potentially leading to breakthroughs in neuroscience and related fields.